INTERNATIONAL PATENT: MORPHIC THERAPEUTIC, INC. FILES APPLICATION FOR "USE OF ANTI-Α5Β1 ANTIBODIES IN THE TREATMENT OF PULMONARY HYPERTENSION AND HEART FAILURE"

GENEVA, May 28 -- MORPHIC THERAPEUTIC, INC. (35 Gatehouse Drive, A2Waltham, Massachusetts 02451) filed a patent application (PCT/US2024/055992) for "USE OF ANTI-Alpha5Beta1 ANTIBODIES IN THE TREATMENT OF PULMONARY HYPERTENSION AND HEART FAILURE" on Nov 14, 2024. With publication no. WO/2025/106724, the details related to the patent application was published on May 22, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WANG, Hua (c/o Morphic Therapeutic, Inc.35 Gatehouse Drive, A2Waltham, Massachusetts 02451), LIN, Fu-Yang (c/o Morphic Therapeutic, Inc.35 Gatehouse Drive, A2Waltham, Massachusett...